Foundation Healthcare and AMILI Announce Strategic Partnership to Advance Microbiome Medicine in Singapore
Freepik
You're reading Entrepreneur Asia Pacific, an international franchise of Entrepreneur Media.
Foundation Healthcare (Specialists) Pte. Ltd., Singapore’s largest private multi-specialty group, has entered a research and clinical collaboration with AMILI Pte. Ltd., Southeast Asia’s first gut microbiome transplant bank.
The partnership will focus on advancing the clinical applications of microbiome science and conducting joint research in microbiome medicine. Foundation Healthcare will introduce gut health testing at selected clinics and provide anonymised clinical data, while AMILI will contribute microbiome and dietary datasets, analytical support, and scientific expertise.
As part of the collaboration, Foundation Ambulatory Centre, a day surgery facility of Foundation Healthcare, will offer Microbiome Restoration Therapy (MRT), which involves transferring stool from a healthy donor to a patient to restore gut microbiome balance, supporting digestive health and immunity.
“At Foundation Healthcare, we aim to make care more coordinated and data-driven. This collaboration enables specialists to deliver personalised care based on microbiome science,” said Liaw Yit Ming.
“This partnership with AMILI allows us to translate microbiome research into practical clinical applications and strengthen clinician expertise through continuing medical education programmes,” said Chua Tju Siang.
Dr Jeremy Lim added, “We look forward to expanding microbiome interventions to more patients in Singapore and the region, supporting better gut health and overall wellbeing.”
The collaboration is expected to generate clinical insights, research outputs, and future publications in microbiome medicine.
About Foundation Healthcare
Foundation Healthcare is Singapore’s largest private multi-specialty group, providing integrated, patient-centred care across 16 specialties. The group operates ambulatory surgery centres and ancillary services, supported by more than 100 in-house medical specialists. More information: www.foundationhealthcare.sg
About AMILI
AMILI is a Singapore-based precision gut microbiome company and Southeast Asia’s first gut microbiome transplant bank. The company combines microbiome sequencing, data analytics, and research to support clinically meaningful, personalised care.
Foundation Healthcare (Specialists) Pte. Ltd., Singapore’s largest private multi-specialty group, has entered a research and clinical collaboration with AMILI Pte. Ltd., Southeast Asia’s first gut microbiome transplant bank.
The partnership will focus on advancing the clinical applications of microbiome science and conducting joint research in microbiome medicine. Foundation Healthcare will introduce gut health testing at selected clinics and provide anonymised clinical data, while AMILI will contribute microbiome and dietary datasets, analytical support, and scientific expertise.
As part of the collaboration, Foundation Ambulatory Centre, a day surgery facility of Foundation Healthcare, will offer Microbiome Restoration Therapy (MRT), which involves transferring stool from a healthy donor to a patient to restore gut microbiome balance, supporting digestive health and immunity.
